The firm will use the funds to continue its commercialization plans for the Unyvero diagnostic test cartridges and instruments.
Funds raised through the offering will be used to buy back shares of common stock from shareholders in privately negotiated transactions.
The company said it will use the proceeds from the offering for general corporate and working capital purposes.
The firm said it intends to use net proceeds from the issuance of the notes for general corporate purposes.
The company said it will use the funds to develop antimicrobial therapeutics based on CRISPR-Cas3 technology.
The Salt Lake City-based company said it would use the $18.4 million in expected gross aggregate proceeds for product pipeline development and customer growth.
The firm privately negotiated the exchange with current holders of convertible notes due 2017.
Quidel will use the net proceeds from the offering for working capital and other general corporate purposes.
PositiveID will issue $4 million in senior secured convertible promissory notes to institutional investor Dominion Capital, the firm announced today.
NEW YORK (GenomeWeb News) – Qiagen said after the close of the market on Wednesday that it successfully completed the previously announced repurchase of convertible notes due in 2026 and the issuance
Researchers in the UK and Australia uncover genetic links between BMI and depression, the Guardian reports.
The Verge details the account of an academic who alleges her university retaliated against her after she complained of sexual harassment by her supervisor.
The New York Times writes that natural history museums are helping round out genetic studies with older specimens.
In PNAS this week: artemisinin resistance mutations in malaria parasites, ant-plant interactions over time, and more.